Reported 28 days ago
Pfizer CEO Albert Bourla expressed confidence following strong Q3 earnings and guidance boost, emphasizing that recent efforts to enhance the company's value have rendered activist investor Starboard's intervention 'too late.' Despite pressure from Starboard after they acquired a $1 billion stake, Bourla believes his strategic initiatives, including significant acquisitions and cost-cutting, have set Pfizer on a path of consecutive growth, making any calls for change now less relevant.
Source: YAHOO